GeneLancet Biosciences
1 known investors
Find your way into GeneLancet Biosciences
12 people in our graph share verified history with the GeneLancet Biosciences team — schools, employers, funds. One of them is your warm intro.
Giuseppe Iademarcounlockedknows Sheri Lin · together at Dalian University of Technology
×11knows the team · via Dalian University of Technology
GeneLancet develops proprietary LgRNA technology for precise gene editing, with applications in CRISPR polymerase-directed therapies targeting neurodegenerative diseases and cancers with unmet medical needs.
Founders & leadership
Investors · 1
Competitors · 1
by search overlap
Companies competing with GeneLancet Biosciences for the same Google search keywords, organic and paid, via search-intersection analysis.
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2022 | $300K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does GeneLancet Biosciences do?
- GeneLancet develops proprietary LgRNA technology for precise gene editing, with applications in CRISPR polymerase-directed therapies targeting neurodegenerative diseases and cancers with unmet medical needs.
- Who are GeneLancet Biosciences's investors?
- GeneLancet Biosciences's investors include The Innovation Space.